We're pleased to announce the extension of funding for the MiNivAn trial, investigating new combination therapies for children with relapsed or refractory high-risk neuroblastoma.

Solving Kids’ Cancer UK is proud to announce a new three-year charity partnership with Julius Baer International Ltd, the UK entity of one of the world’s leading wealth management firms.

Solving Kids’ Cancer UK are pleased to announce renewed funding for the Cancer Research Clinical Trials Unit (CRCTU) at the University of Birmingham.

This April, we're uniting with charities to raise awareness of the unique challenges facing young people when diagnosed with cancer.

An update from the research team on their recent trip to Brussels for the ACCELERATE annual conference.

Solving Kids’ Cancer UK and Neuroblastoma UK have entered into a formal collaboration to speed up the development of new, better treatments for children with neuroblastoma.

Solving Kids' Cancer UK responds to the announcement of a government-led Childhood Cancer Taskforce

Research Engagement and Advocacy Manager Emily gives an update on the activities of our Research team ahead of the holiday season.

Solving Kids' Cancer UK has launched their first External Affairs strategy, aiming to improve the clinical research landscape in the UK for children with cancer.